Bempedoic Acid is a first-in-class ATP citrate lyase (ACL) inhibitor used for LDL cholesterol lowering in patients with hyperlipidemia and atherosclerotic cardiovascular disease (ASCVD). It offers a statin-alternative or add-on option, especially beneficial for statin-intolerant individuals. Bempedoic Acid targets cholesterol synthesis in the liver, minimizing muscle-related side effects and providing a novel approach to lipid management.

Explore Royal Pharma as your potential partner for Bempedoic Acid API.